Somnolence: Difference between revisions

Jump to navigation Jump to search
Line 25: Line 25:
* [[Delayed sleep phase syndrome]]
* [[Delayed sleep phase syndrome]]
* [[Diabetic ketoacidosis]] as example, but not balanced diabetes mellitus
* [[Diabetic ketoacidosis]] as example, but not balanced diabetes mellitus
* Drug Side Effect-[[Brompheniramine maleate and Pseudoephedrine hydrochloride]], [[caspofungin acetate]], [[Cyclobenzaprine]], [[Eletriptan]], [[Fesoterodine]], [[Ketorolac tromethamine]], [[Levetiracetam]], [[Naproxen sodium]], [[Oxcarbazepine]], [[Prochlorperazine]], [[Progesterone]]
* Drug Side Effect-[[Brompheniramine maleate and Pseudoephedrine hydrochloride]], [[caspofungin acetate]], [[Clozapine]], [[Cyclobenzaprine]], [[Eletriptan]], [[Fesoterodine]], [[Ketorolac tromethamine]], [[Levetiracetam]], [[Naproxen sodium]], [[Oxcarbazepine]], [[Prochlorperazine]], [[Progesterone]]
* [[Encephalitis]] – (viral, bacterial or other agents)
* [[Encephalitis]] – (viral, bacterial or other agents)
* [[Epilepsy]]
* [[Epilepsy]]

Revision as of 06:01, 13 December 2014

For patient information, click here

Somnolence
ICD-10 R40.0
ICD-9 780.09

Template:Search infobox Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] ; Associate Editor(s)-in-Chief: Pratik Bahekar, MBBS [2]

Overview

Somnolence (or "drowsiness") is a state of near-sleep, a strong desire for sleep, or sleeping for unusually long periods. It has two distinct meanings, referring both to the usual state preceding falling asleep, and the chronic condition referring to being in that state independent of a circadian rhythm. The disorder characterized by the latter condition is most commonly associated with users of prescription hypnotics, such as mirtazapine or zolpidem.

It is considered a lesser impairment of consciousness than stupor or coma.

Causes

Hazards

Somnolence can be dangerous when performing tasks that require constant concentration, such as driving a vehicle. When a person is sufficiently fatigued, he or she may experience microsleeps (loss of concentration).

See also

References

  1. Zimmermann C, Pfeiffer H (January 2007). "[Sleep disorders in depression. Suggestions for a therapeutic approach]". Nervenarzt (in German). 78 (1): 21–30. doi:10.1007/s00115-006-2111-1. PMID 16832696.
  2. Watanabe N, Omori IM, Nakagawa A; et al. (2011). "Mirtazapine versus other antidepressive agents for depression". Cochrane Database Syst Rev (12): CD006528. doi:10.1002/14651858.CD006528.pub2. PMID 22161405.
  3. "http://www.dsm5.org/Pages/Default.aspx". External link in |title= (help)

Template:Cognition, perception, emotional state and behaviour symptoms and signs Template:SleepSeries2

Template:Disease-stub